Molecular substrates of anxiety: clues from the heterogeneity of benzodiazepine receptors.
D000375:Aging; D000818:Animals; D001007:Anxiety / Q000503:physiopathology*; D001569:Benzodiazepines / Q000378:metabolism / Q000494:pharmacology; D001667:Binding, Competitive; D001921:Brain / Q000378:metabolism; D002243:Carbolines / Q000494:pharmacology; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D005445:Flunitrazepam / Q000378:metabolism; D006801:Humans; D009132:Muscles / Q000187:drug effects; D010433:Pentylenetetrazole / Q000494:pharmacology; D011724:Pyridazines / Q000494:pharmacology; D011955:Receptors, Drug / Q000187:drug effects / Q000502:physiology*; D011963:Receptors, GABA-A; D014018:Tissue Distribution; D014230:Triazoles / Q000494:pharmacology
D002243:Carbolines; D011724:Pyridazines; D011955:Receptors, Drug; D011963:Receptors, GABA-A; D014230:Triazoles; D001569:Benzodiazepines; D005445:Flunitrazepam; C021604:CL 218872; C024915:beta-carboline-3-carboxylic acid ethyl ester; D010433:Pentylenetetrazole